Archived News

ASCO GU 2018: Serum miRNA to Predict Post-chemotherapy Viable Disease in Testicular Non-seminomatous Germ..

..Published 12 February 2018; San Francisco, CA ( Dr. Leao presented his work exploring the role of serum miRNA in predicting viable disease post-chemotherapy in non-seminoma germ cell tumors (NSGCT). This was a work led by Dr. Robert..
UroToday. Feb 12, 2018 13:56 UTC

Access to the post

Note: This is an archived weblink and the information may be outdated or no longer relevant.

Check the box if you have read and agree to our Terms & Privacy.

Access this URL with Proxy Service

More Information

Recent Posts



We may use cookies to give you the best experience. If you do nothing we'll assume that it's ok.

Terms & Privacy

The information forward from this site may be provided by third parties. We will not be responsible with outside links, contents from source of information, methods of using, using or consequence of contents with users. All direct or indirect risk related to use of this site is borne entirely by you, the user.

We use advertising companies as Google AdSense, to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, see